35 related articles for article (PubMed ID: 38553809)
1. [Progress in targeting therapy of cancer metastasis by CCL21/CCR7 axis].
Zhang L; Wang F; Yao X; Ma S; Zhang L; Qin Z
Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2741-2754. PubMed ID: 33398969
[TBL] [Abstract][Full Text] [Related]
2. CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer.
Yang S; Dong D; Bao X; Lu R; Cheng P; Zhu S; Yang G
Cancer Control; 2024; 31():10732748241238616. PubMed ID: 38553809
[TBL] [Abstract][Full Text] [Related]
3. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.
Shi M; Chen D; Yang D; Liu XY
J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143
[TBL] [Abstract][Full Text] [Related]
4. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
[TBL] [Abstract][Full Text] [Related]
5. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
6. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
7. CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis.
Hwang TL; Lee LY; Wang CC; Liang Y; Huang SF; Wu CM
World J Gastroenterol; 2012 Mar; 18(11):1249-56. PubMed ID: 22468089
[TBL] [Abstract][Full Text] [Related]
8. A local subset of mesenchymal cells expressing the transcription factor Osr1 orchestrates lymph node initiation.
Vallecillo-García P; Orgeur M; Comai G; Poehle-Kronawitter S; Fischer C; Gloger M; Dumas CE; Giesecke-Thiel C; Sauer S; Tajbakhsh S; Höpken UE; Stricker S
Immunity; 2023 Jun; 56(6):1204-1219.e8. PubMed ID: 37160119
[TBL] [Abstract][Full Text] [Related]
9. The functions and prognostic values of chemokine and chemokine receptors in gastric cancer.
He C; He L; Lu Q; Xiao J; Dong W
Am J Cancer Res; 2022; 12(7):3034-3050. PubMed ID: 35968351
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
11. CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.
Fu Q; Tan X; Tang H; Liu J
J Transl Med; 2021 May; 19(1):210. PubMed ID: 34001131
[TBL] [Abstract][Full Text] [Related]
12. lncRNA PCAT18 inhibits proliferation, migration and invasion of gastric cancer cells through miR-135b suppression to promote CLDN11 expression.
Zhang XZ; Mao HL; Zhang SJ; Sun L; Zhang WJ; Chen QZ; Wang L; Liu HC
Life Sci; 2020 May; 249():117478. PubMed ID: 32119960
[TBL] [Abstract][Full Text] [Related]
13. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.
Tian S; Peng P; Li J; Deng H; Zhan N; Zeng Z; Dong W
Aging (Albany NY); 2020 Feb; 12(4):3574-3593. PubMed ID: 32091407
[TBL] [Abstract][Full Text] [Related]
14. CCL21 Expression in β-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice.
Gonzalez Badillo FE; Zisi Tegou F; Abreu MM; Masina R; Sha D; Najjar M; Wright SH; Bayer AL; Korpos É; Pugliese A; Molano RD; Tomei AA
Diabetes; 2019 Oct; 68(10):1990-2003. PubMed ID: 31371518
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
